Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

A woman was diagnosed with a rare adrenal gland cancer that did not show usual hormone-related symptoms.

Non-classic congenital adrenal hyperplasia (NCCAH) can mimic PCOS and requires genetic testing for proper diagnosis and treatment.

Skin changes can help diagnose and manage endocrine disorders like thyroid problems, diabetes, and adrenal gland conditions.

Dogs with sex hormone imbalances may not drink or pee a lot but often lose hair on their body and can have reproductive system issues.

Skin problems in older people can indicate hormonal diseases, nutritional deficiencies, or conditions like diabetes, menopause, and HIV.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

The document concludes that early diagnosis and treatment are crucial for managing skin diseases in ferrets.

Some conditions mimic PCOS symptoms and need careful diagnosis to treat potentially serious health issues.

A woman with anorexia and Cushing's syndrome improved after tumor removal, highlighting the need to consider hormonal issues in psychiatric conditions.

A man with a rare adrenal cancer showed unusual symptoms and died four months after diagnosis.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

Hirsutism can be caused by various conditions besides PCOS, and it's important to treat the underlying issue and manage symptoms with medication and cosmetic approaches.

The conclusion is that accurately identifying the cause of high androgen levels in women with PCOS is crucial and requires specific tests.

Skin problems can be signs of hormone-related disorders and recognizing them early is important for treatment.

Different growth patterns in thyroid tumors are influenced by where cell growth and death occur.

The conclusion is that PCOS is a common cause of hirsutism in young obese women, and early treatment is important to reduce the risk of metabolic syndrome.

Hair loss improved after removing pituitary tumor.

Neutered ferrets often develop hyperadrenocorticism, with symptoms like hair loss and lethargy, and androstenedione is a key indicator for diagnosis.

A toddler with a rare adrenal gland tumor causing male-like physical changes was successfully treated with surgery.

Always consider xanthomatous hypophysitis before deciding on pituitary surgery.

A woman's high testosterone and related symptoms were caused by overactive cells in her ovaries.

Excessive hair growth in women can be harmless or signal serious health issues, and treatment often includes medication and hair removal, with noticeable results after 3-6 months.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

The case showed the need for quick investigation of virilization in women and how emotional health is linked to physical health.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

People with reproductive, thyroid disorders, and type 2 diabetes can experience voice changes, but more research is needed to understand this better.

Early diagnosis and hormone therapy can significantly improve outcomes for post-partum pituitary insufficiency in resource-limited settings.